LAURIE KOMUDA: Open Payments
NPI 1942759568 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 11 payments from 6 companies in 2025. Trend: 2023 $1,122 · 2024 $475 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: FANAPT, INVEGA, HETLIOZ, REXULTI, UZEDY, ABILIFY MAINTENA, VIVITROL.
Industry payments across NY — which companies pay providers there.
